Global Gallic acid (CAS 149-91-7) Market Insights, Forecast to 2025

Gallic Acid (CAS 149-91-7) is a trihydroxybenzoic acid, a type of phenolic acid, a type of organic acid, also known as 3, 4, 5-trihydroxybenzoic acid, founded in gallnuts, sumac, witch hazel, tea leaves, oak bark, and other plants. The chemical formula is C6H2 (OH)3COOH.
The leading manufactures mainly are Jiurui Biology, Bei Yuan Chemical, Hunan Linong, Tianxin Biotech and GALLOCHEM. Jiurui Biology is the largest manufacturer; its revenue of global market exceeds 27% in 2017.
Geographically, the global Gallic Acid market has been segmented into North America, Europe, China, India and RoW. The China held the largest production share in the global market, its revenue of global production market exceeds 85% in 2017.
Global Gallic acid (CAS 149-91-7) market size will increase to 100 Million US$ by 2025, from 58 Million US$ in 2018, at a CAGR of 7.3% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gallic acid (CAS 149-91-7).

This report researches the worldwide Gallic acid (CAS 149-91-7) market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Gallic acid (CAS 149-91-7) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Jiurui Biology
Bei Yuan Chemical
Hunan Linong
Tianxin Biotech
GALLOCHEM
Xiangxi Gaoyuan
Chicheng Biotech
JPN Pharma
Hunan Shineway
WENZHOU OUHAI

Gallic acid (CAS 149-91-7) Breakdown Data by Type
Industrial Grade
Pharmaceutical Grade
Food Grade
Gallic acid (CAS 149-91-7) Breakdown Data by Application
Antioxidants
Biological Activity
Medical Applications
Other

Gallic acid (CAS 149-91-7) Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Gallic acid (CAS 149-91-7) Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Gallic acid (CAS 149-91-7) capacity, production, value, consumption, status and forecast;
To focus on the key Gallic acid (CAS 149-91-7) manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gallic acid (CAS 149-91-7) :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.